The global oncology platform OncoDaily has announced the selection of HE Sheikh Dr Khalid bin Jabor al-Thani, chairman of Qatar Cancer Society (QCS), among the Top 100 Most Influential Figures in Oncology for 2025.
The recognition comes in appreciation of his outstanding contributions to advancing cancer care, supporting public health policies, strengthening healthcare systems, and promoting cancer awareness, patient advocacy, medical education, and scientific research.
It also reflects the advanced position of Qatar in cancer control efforts, highlighting the growing global influence of Qatari healthcare leadership in shaping oncology-related policies and enhancing cancer services in line with international best practices. It also underscores the vital role of the QCS as a leading national institution in patient support, community awareness, and the development of effective local and international partnerships.
Sheikh Dr Khalid expressed his pride in the recognition, emphasising that it represents a collective national accomplishment rather than an individual one. He stated that the international acknowledgement reflects the confidence of the global medical community in Qatar’s integrated healthcare approach, which prioritises prevention, early detection, and advanced treatment while placing patients at the centre of care.
He added that the recognition serves as a greater responsibility to further develop programmes and services, expand partnerships, and ensure comprehensive and sustainable support for cancer patients, survivors, and their families.
In 2025, QCS supported the treatment of more than 1,750 adult and paediatric patients receiving care at the National Centre for Cancer Care and Research and Sidra Medicine, at a total cost exceeding QR49mn. In the field of psychosocial support, 1,200 individuals benefited directly from community-based programmes, while more than 40,000 indirect beneficiaries were reached through digital platforms.
In addition, 50 cancer survivors received specialised one-on-one psychological support. Community awareness remained a core focus, with campaigns reaching over 6.6mn indirect beneficiaries through digital channels, alongside nearly 19,000 participants in workshops, educational programmes, and field activities across Qatar.
As part of ongoing efforts to enhance professional development and support scientific research in the field of cancer, the total number of beneficiaries reached 16,248, reflecting a pivotal role in strengthening competencies, advancing research and development, and contributing to sustainable professional development goals.
As for partnerships and institutional achievements, QCS recorded several milestones in 2025, including membership in Qatar’s National Cancer Control Framework, the Gulf Federation for Cancer Control, and the Union for International Cancer Control.
It also won the Qatar Social Responsibility Award 2025, secured the rights to host the global Relay for Life event, established 17 strategic partnerships, and implemented more than 80 awareness initiatives in collaboration with schools, universities, and various institutions.
Founded in 1997, QCS operates as a charitable organisation and represents a key pillar in Qatar’s national cancer control ecosystem. QCS works to build a cancer-aware community and improve the quality of life of those affected by the disease through awareness programmes, financial assistance, and psychosocial support, among other initiatives.